LHLabcorp

$366.64+46% 1Y

What has happened

LH in its own filings

LH's filing record carries one kind of hard flag, each is shown beside the share of the whole market carrying the same one, because more than half of all companies carry at least one.

1,338

Events found in the filings · across 3,901 filings · the record starts in 1994

Hard flags
1

Hard flags · all historical, the latest in 1997

Most recent filing
Nov 4, 2026

Most recent filing · Form 8-K

Record starts
Jul 8, 1994

Record starts · the earliest filing Ryufin holds for this name

Details›
Next results filingsame week as a year ago
expected around Feb 16, 2027
Change in certifying accountant2 occurrences
2021-03-03
Late periodic reporthistorical
1997-03-31
Security removed from listing or deregisteredpast_3y · usually a matured note or preferred class, not the common shares
2024-05-20
SEC comment-letter activity33 occurrences
2017-05-09

SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.

What the company said

The company's own words from its current reports to the SEC, newest first

  1. Regulation FD disclosure
    Labcorp to Speak at the UBS Global Healthcare Conference.
    The press release on sec.gov ↗
  2. Earnings release
    Nickolo Russo - Investors.
    The press release on sec.gov ↗
  3. Regulation FD disclosure
    Labcorp Declares Quarterly Dividend.
    The press release on sec.gov ↗
Earlier reports (8)›
  1. Regulation FD disclosure
    Labcorp to Announce Third Quarter Financial Results on October 28, 2026.
    The press release on sec.gov ↗
  2. Regulation FD disclosure
    Labcorp Highlights Strategic Priorities Driving Durable Growth.
    The press release on sec.gov ↗
  3. Regulation FD disclosure
    Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference.
    The press release on sec.gov ↗
  4. Regulation FD disclosure
    Labcorp to Host Investor Day on September 10, 2026.
    The press release on sec.gov ↗
  5. Director or officer change
    On August 11, 2026, Megan D. Bailey notified Labcorp Holdings Inc. (the “Company”) of her decision to resign as Executive Vice President and President, Central Laboratories and International of the Company, effective September 4, 2026.
    Form 8-K on sec.gov ↗
  6. Earnings release
    Dewey Steadman - Investors.
    The press release on sec.gov ↗
  7. Regulation FD disclosure
    Labcorp Declares Quarterly Dividend.
    The press release on sec.gov ↗
  8. Regulation FD disclosure
    Labcorp to Announce Second Quarter Financial Results on July 30, 2026.
    The press release on sec.gov ↗
What every company told the SEC this week ›

Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.

opening the record…